Skip to main content
NCBI home page
Journal of Inflammation (London, England) logoLink to Journal of Inflammation (London, England)
. 2021 May 22;18:18. doi: 10.1186/s12950-021-00281-9

VEGF as a potential molecular target in periodontitis: a meta-analysis and microarray data validation

Bo Ren 1,#, Que Feng 1,#, Shan He 1,#, Yanfeng Li 1,✉, Jiadong Fan 1,✉, Guangquan Chai 1,✉, Le Liu 1, Haiyun Liu 1, Chunhao Yang 1, Yingdi Wang 1, Huihui Liu 1, Huanyue Liu 1, Yafan Song 1
PMCID: PMC8140513  PMID: 34022893

Abstract

Background

Anti-vascular endothelial growth factor (VEGF) has been used as a therapeutic drug for the treatment of some human diseases. However, no systematic evidence is performed for assessing the role of VEGF in periodontitis. We carried out a comprehensive analysis to explore the role of VEGF in patients with periodontitis.

Methods

Multiple databases were searched for eligible studies. The pooled standardized mean difference (SMD) and odds ratio (OR) with the corresponding 95% confidence interval (CI) were applied to evaluate the effect sizes. Clinical data validation from microarray analysis was used. Pathway and process enrichment analysis were also investigated.

Results

Finally, 16 studies were included in this analysis. Overall, there was a significantly higher level of VEGF expression in periodontitis than in healthy control groups (OR = 16.64, 95% CI = 6.01–46.06, P < 0.001; SMD = 2.25, 95% CI = 1.25–3.24, P < 0.001). Subgroup analysis of ethnicity showed that VEGF expression was still correlated with periodontitis in the Asian and European populations. No correlation was observed between VEGF expression and age, gender, and pathological type. A large clinical sample data (427 periodontitis patients and 136 healthy controls) further validated that VEGF expression was higher in periodontitis than in healthy control groups (P = 0.023). VEGF was involved in many functions such as blood vessel development, response to growth factor, cell proliferation, and cell adhesion.

Conclusions

High levels of VEGF were credible implications for the development of periodontitis. Anti-VEGF therapy may be valuable for the treatment of periodontitis in clinical management.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12950-021-00281-9.

Keywords: VEGF, Function, Periodontitis, Development, Clinical

Background

Periodontitis, one of the most common inflammatory diseases, is caused by the host inflammatory response and the oral microbiome and affects periodontal connective tissue [1, 2]. Periodontitis is recognized as a major public health problem with the global cost burden. It impacts approximately 10–15% of the population in the world [3, 4]. The diagnosis of periodontitis is currently based on clinical rather than etiologic aspect, which can result in limited therapeutic guidance [5]. Hence, it is of great importance to explore potential molecular targets and further conduct effective prevention for patients with periodontitis.

Genetic and epigenetic molecular mechanisms are shown to be contributed to the development of periodontitis [6, 7]. Angiogenesis is closely related to some biological processes (i.e., embryonic development, reproduction, tissue repair, and wound repair) and may play a key role in the pathogenesis of some inflammatory diseases such as periodontitis [8, 9]. Vascular endothelial growth factor (VEGF), mapped to the 6p21.3 chromosome, is a critical potent pro-angiogenic factor and has been implicated in angiogenesis [10]. VEGF is involved in many biological functions such as cell proliferation, cell adhesion, and chemotaxis [11, 12]. VEGF expression has been reported to be higher in some cancers than in healthy control groups and to be correlated with poor prognosis [13, 14]. As an anti-angiogenic drug, anti-VEGF by the U.S. FDA approval has been administered for the therapy of some cancers [15]. However, the role of VEGF in the pathogenesis of periodontitis has not been fully elucidated. The results on VEGF in periodontitis were still conflicting. For example, VEGF expression shows no difference between periodontitis and healthy control groups [16]. Balci 2019 et al. reported that VEGF expression was higher in periodontitis than in healthy control groups [17].

Therefore, in order to explore a full insight into the role of VEGF expression in periodontitis, we first performed a meta-analysis based on available studies. Moreover, independent clinical data were also used to verify the results and pathway and process analyses were also investigated in periodontitis, which could provide systematic evidence for a better understanding of periodontitis etiology and develop potential therapeutic targets in clinical practice.

Methods

Search strategy

The current meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) statement [18]. We performed a comprehensive literature search from the PubMed, Embase, Web of Science, Wanfang, and CNKI databases for studies published until March 19, 2020. The keywords and search terms used were shown as follows: “vascular endothelial growth factor OR VEGF OR VEGF-A OR VEGFA”, “periodontitis OR periapical periodontitis OR periodontal abscess OR periodontal disease”. We also hand searched the reference lists from the included publications to identify additional studies.

Study selection

If studies fulfilling the following inclusion criteria were included in this meta-analysis: 1) periodontitis patients were clinically or pathologically diagnosed and healthy control group without a history of periodontitis and other diseases; 2) the expression level of VEGF was reported from original clinical studies; 3) studies provided available data for calculating standardized mean difference (SMD) or odds ratio (OR) with 95% confidence interval (CI). If authors published multiple papers using overlapping sample study population, we only included the study containing most comprehensive information or the recent study. If data were not directly reported, we would contact the corresponding author via email. Exclusion criteria were mainly listed as follows: 1) periodontitis patients with systematic disorders such as diabetes mellitus, etc.; 2) case reports, reviews, conference abstracts, editorial letters, comments, or non-human researches; 3) duplicate studies; 4) studies with insufficient available data.

Data extraction

The following data were extracted from the eligible publications: first author’s surname, publication year, country, ethnicity, sample size, age of participants (mean or median age), VEGF levels (mean and standard deviation), VEGF expression levels (frequency), and test method, etc. If the data were not directly reported, we would contact the corresponding author through email as possible as we can. If there were any disagreements, disagreements were resolved by the discussion of all authors.

Further clinical data validation from microarray analysis

The normalized gene expression profiles of microarray datasets for periodontitis were obtained from the Gene Expression Omnibus (GEO). Three datasets of tissue samples with periodontitis, GSE10334, GSE16134, and GSE23586 were used. For the GSE23586 dataset, we conducted a log2 transformation. To achieve a large sample population, batch effects were adjusted with the ComBat function for these three datasets [19]. Finally, 563 tissue samples involving in 427 patients with periodontitis and 136 healthy controls were identified for VEGF expression analysis.

Pathway and process enrichment analysis

The Spearman correlation between VEGF and genes was calculated in periodontitis, and the corresponding genes with the correlation with > 0.4 were selected. Based on these significant genes, Metascape, an effective and efficient tool for experimental biologists [20], was applied to investigate the function of VEGF.

Statistical analysis

With regard to data of mean and standard deviation (SD), the SMDs with 95% CIs were used to compare the levels of VEGF in the patients with periodontitis and the levels in healthy controls. For categorical data, the pooled ORs and their corresponding 95% CIs were used. The random-effects model was applied to estimate the pooled effect size (SMD and OR) in this meta-analysis. Heterogeneity among the studies was measured using Cochran’s Q statistics test [21], the statistical heterogeneity was significant for a Q test P-value < 0.1. When significant heterogeneity was detected, a sensitivity analysis through deleting each study was carried out to determine the stability of the pooled results. Publication bias was conducted by using the Begg’s and Egger’s test [22, 23]. This meta-analysis was performed using Stata software, version 12.0 (Stata Corp., College Station, TX, USA).

For bioinformatics validation data, the difference of VEGF between periodontitis and healthy control groups was analyzed with the Wilcoxon signed-rank test. Spearman correlation coefficient between VEGF and genes was analyzed. The corresponding analyses were conducted using the R software version 3.5.1 (Institute for Statistics and Mathematics, Vienna, Austria).

Results

Study characteristics

The flow diagram of the initial search strategy is shown in Fig. 1. According to the inclusion criteria, 16 studies from 13 publications containing 1532 participants (566 patients with periodontitis and 966 healthy controls) were identified [17, 24–35]. These studies were published between 2000 and 2019 and were conducted in Turkey, India, China, Japan, Italy, and Poland. Of these studies, three studies reporting categorical data evaluated the correlation of VEGF between periodontitis and healthy control groups [29, 32, 34]; the remaining studies reporting mean and standard deviation (SD) evaluated the difference between the VEGF expression levels in periodontitis. The main characteristics of the included publications are summarized in Table S1, Table 1.

Fig. 1.

Fig. 1

Open in a new tab

Flowchart of the study selection process

Table 1.

Study characteristics of the included studies on VEGF levels

First author Country Ethnicity Age Method Histology Source of Ab Staining Case (N) Control (N) Case Healthy control
Mean SD Mean SD
Yuan 2000 China Asian 32 IHC Periodontitis NA Cytoplasm 15 15 0.6 0.27 0.38 0.21
Kubota 2001 Japan Asian 28–42 RT-PCR Aggressive periodontitis NA NA 6 8 5.34 1.36 3 1.27
Kubota 2001 Japan Asian 55–71 RT-PCR Chronic periodontitis NA NA 6 4.95 0.91
Lucarini 2009 Italy European 47 IHC Periodontitis dil. 1:200; Santa Cruz Biotechnology, Santa Cruz, CA, USA Epithelial cells 16 16 40 14.14 10 2.6
Artese 2010 Italy European <  35 IHC Aggressive periodontitis diluted at 1:100 Oral epithelium 6 7 74 2.28 27.85 1.95
Artese 2010 Italy European >  35 IHC Chronic periodontitis diluted at 1:100 Oral epithelium 14 56.28 3.51
Loo 2011 China Asian 48 ELISA Chronic periodontitis Diaclone, France NA 280 250 126.3 56.086 42.76 14.17
Kasprzak 2012 Poland European 43 IHC Chronic periodontitis clone VG1, 1:50, DAKO HEVs and ordinary/inflammatory infiltrate cells 40 15 3.57 5.02 0.02 0.04
Tian 2013 China Asian 54 ELISA Chronic periodontitis Phoenix Pharmaceuticals, Inc., USA NA 122 532 127.88 52.13 40.13 13.63
Balci 2019 Turkey European 47.25 IHC Chronic periodontitis diluted 1:100, Abcam Inflammatory cells 16 16 219.72 30.48 93.29 51.07
Taskan 2019 Turkey European 40.37 IHC Periodontitis (D-GradeB) diluted 1:250 Inflammatory cells 15 15 98.74 3.73 122.7 17.37
Taskan 2019 Turkey European 35.25 IHC Periodontitis (D-GradeC) diluted 1:250 Inflammatory cells 15 98.25 4.09
Li 2014 China Asian 35–76 IHC Chronic periodontitis NA Endothelial cells, stromal cells/inflammatory cells 15 15 83.53 7 41.87 5.97
Open in a new tab

RT-PCR reverse transcription-polymerase chain reaction, ELISA enzyme-linked immunosorbent assay, IHC immunohistochemistry, Ab antibody, N the number of the study population, SD standard deviation

VEGF expression in periodontitis and normal controls

For categorical data, the results from three studies showed that VEGF expression was higher in the periodontitis group than the healthy control group (OR = 16.64, 95% CI = 6.01–46.06, P < 0.001), including 67 periodontitis patients and 77 healthy controls (Fig. 2).

Fig. 2.

Fig. 2

Open in a new tab

Comparison of the difference of VEGF expression between periodontitis and control groups based on the pooled odds ratio (OR) with 95% confidence interval (CI)

For continuous data, the pooled results from 13 studies also demonstrated a significant association between VEGF expression and periodontitis (SMD = 2.25, 95% CI = 1.25–3.24, P < 0.001), including 566 periodontitis patients and 889 healthy controls (Fig. 3).

Fig. 3.

Fig. 3

Open in a new tab

Comparison of the difference of VEGF levels between periodontitis and control groups based on the pooled standardized mean difference (SMD) with 95% confidence interval (CI)

Association of VEGF expression with the clinical and pathological characteristics of periodontitis

Data from two studies with 27 periodontitis patients showed no association between VEGF expression and age (≥ 50 vs. < 50 years: OR = 0.23, 95% CI = 0.02–2.72, P = 0.241) and gender (male vs. female: OR = 0.38, 95% CI = 0.05–2.87, P = 0.35) (Fig. 4a). Additionally, data from two studies involving 32 patients with periodontitis showed no correlation between VEGF expression and disease type (aggressive vs. chronic periodontitis: SMD = 2.85, 95% CI = − 2.22-7.92, P = 0.27) (Fig. 4b).

Fig. 4.

Fig. 4

Open in a new tab

Association between VEGF expression and the clinical and pathological characteristics of periodontitis. a age (≥ 50 vs. < 50 years) and gender, (male vs. female); b pathological type (aggressive vs. chronic type). OR: odds ratio; CI: confidence interval; SMD: standardized mean difference

Subgroup analysis

Subgroup analyses were carried out based on the available information (Table 1). The results by ethnicity showed that VEGF expression was correlated with periodontitis in Asians (SMD = 2.53, P < 0.001) and Europeans (SMD = 2.53, P = 0.02).

In the subgroup analysis of the testing method, we found that VEGF expression was sensitive to reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), and immunohistochemistry (IHC) methods (all P values < 0.01).

Heterogeneity analysis

As shown in Table 1, because all P values of heterogeneity were not more than 0.1, subgroup analyses based on ethnicity, testing method, and sample size demonstrated that these factors could not explain the potential sources of heterogeneity. In the sensitivity analysis, we removed each individual study to assess the influence and change of the re-calculated results. The results showed that no individual study significantly change heterogeneity and the pooled results (Table S2).

Publication bias

Using the Begg’s and Egger’s test, no publication bias was observed between VEGF and periodontitis (all P values > 0.05) (Fig. S1).

Further clinical data validation and pathway and process enrichment analysis

A large study population with 427 patients with periodontitis and 136 healthy controls was used to validate VEGF expression in periodontitis and control groups. The result revealed that VEGF expression was still higher in periodontitis than in healthy controls (P = 0.023) (Fig. 5a). To determine the functions of VEGF, pathway and process enrichment analysis showed that VEGF was predominantly involved in blood vessel development, response to growth factor, cell proliferation, and cell adhesion, etc. (Fig. 5b).

Fig. 5.

Fig. 5

Open in a new tab

clinical data validation and pathway and process enrichment analysis. a VEGF expression in periodontitis and healthy control groups; b VEGF involved in the pathway and process enrichment analysis

Discussion

Periodontitis is widely prevalent in many countries and causes a major global social and economic impact. It is urgent and crucial to prevent and control periodontitis [4, 36]. Microbiome and environmental factors have been considered as potential risk factors for periodontitis [37]. In recent years, increasing evidence suggests that genomic programming is closely implicated in the pathogenesis of periodontitis [38–40]. VEGF, located on chromosome 6p21.3, is reported to be involved in many biological roles such as cell proliferation, cell adhesion, chemotaxis, regulation of blood vessel development, hematopoietic stem cell development, extracellular matrix remodeling, and inflammatory cytokine regeneration, etc. [10–12, 41, 42]. The role of anti-VEGF could serve as anti-vascular, anti-angiogenic, anti-permeability, or immunomodulator factor. In the era of precision medicine, the VEGF blockade could become a promising and optimal strategy for therapeutic intervention [43]. VEGF has been implicated in many diseases [44–46]. For example, VEGF -634G > C polymorphism is correlated with diabetic retinopathy risk [47]. VEGF expression can predict poor survival in esophageal carcinoma [46]. The expression of VEGF is associated with metabolic syndrome or its components [44]. Recently, some studies have reported that VEGF expression can be detected in periodontitis [17, 30, 31]. However, the results of VEGF expression in periodontitis and controls were still inconsistent [16, 17]. Here, we performed a systematic analysis to investigate whether VEGF could be a promising therapeutic method for periodontitis.

We determined whether VEGF expression was associated with periodontitis. The results of the current meta-analysis via pooling available publications showed that VEGF expression was significantly higher in patients with periodontitis than in healthy controls, which was in agreement with the previous studies on the correlation between periodontitis and healthy control groups [17, 24, 27, 29, 31]. An extensive clinical sample data (427 periodontitis patients and 136 healthy controls) was also used to validate the finding of our meta-analysis, and we observed that VEGF expression remained higher in periodontitis than healthy control groups. Further pathway and process enrichment analysis suggested that VEGF was also involved in blood vessel development, response to growth factor, cell proliferation, and cell adhesion, etc. Moreover, subgroup analysis of ethnicity demonstrated that VEGF expression was still related to periodontitis in the Asian and European populations. These suggested that VEGF was closely involved in periodontitis pathogenesis and had the potential to become a therapeutic strategy in the treatment of periodontitis. Interestingly, subgroup analysis of the testing method showed that RT-PCR, ELISA, and IHC methods were sensitive to the detection of VEGF expression.

We also evaluated whether VEGF expression was correlated with the clinical and pathological characteristics of periodontitis and found no correlation between VEGF expression and age, gender, and pathological type. These findings were consistent with the previous studies on age [29, 32] and gender [29, 32]. However, the results should be carefully considered with caution, only two studies with small sample sizes were induced in this meta-analysis. In the future, more studies with a large study population are needed to confirm the findings between VEGF expression and age, gender, and pathological type of periodontitis.

This meta-analysis had several limitations that should be included. First, this meta-analysis consisted of Asians and Europeans, other ethnic groups, such as Africans were insufficient. Second, although subgroup and sensitivity analyses were conducted, ethnicity, testing method, sample size, and individual study could not explain the potential sources of heterogeneity. The potential reasons for heterogeneity were not very clear. Perhaps the different range of mean and SD values of VEGF levels from the original articles, which may result in the potential heterogeneity. Third, analyses between VEGF expression and age, gender, and pathological type were based on only two studies.

Conclusion

In conclusion, our results suggested that VEGF expression had a significantly higher level in periodontitis than in healthy controls. VEGF was involved in some functions such as blood vessel development, response to growth factor, cell proliferation, and cell adhesion, etc. Targeting VEGF has the potential to serve as an efficient therapeutic approach for periodontitis in clinical management. In the future, more studies with larger sample sizes and multi-center design are required to gain definitive conclusions.

Supplementary Information

Additional file 1:. (346.2KB, tif)
12950_2021_281_MOESM2_ESM.docx (17.8KB, docx)

Additional file 2: Table S1. Study characteristics of the included studies on VEGF positive expression.

12950_2021_281_MOESM3_ESM.docx (15.3KB, docx)

Additional file 3: Table S2. Sensitivity analysis.

Acknowledgements

None.

Abbreviations

VEGF

Anti-vascular endothelial growth factor

SMD

Standardized mean difference

OR

Odds ratio

CI

Confidence interval

SD

Standard deviation

RT-PCR

Reverse transcription-polymerase chain reaction

ELISA

Enzyme-linked immunosorbent assay

IHC

Immunohistochemistry

Authors’ contributions

YL, GC, and LL contributed to the conception and design of this research. All authors contributed to the completion of articles and data extraction. BR, SH, and QF contributed to data calculated and the design of figures and tables. All authors approved the final manuscript.

Funding

The study supported by the Clinical Research Support Fund of PLA General Hospital (2018FC-304 M-TSYS-05); the Capital Characteristic Clinical Application Research and Achievement Promotion Project of China (Z171100001017154); Key Project of Transformation Medicine of General Hospital of PLA (2017TM-030) and Capital’s Funds for Health Improvement and Research (No.CFH2020-2-5021). The funder didn’t make any substantial contributions to the research of the article.

Availability of data and materials

The datasets used or/and analyzed during the current study are available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Gene Expression Omnibus Human Subjects Protection and Data Access Policies. Informed consent is not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no conflict of interest.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Bo Ren, Shan He and Que Feng contributed equally to this work.

Contributor Information

Yanfeng Li, Email: 949427779@qq.com.

Jiadong Fan, Email: 359117684@qq.com.

Guangquan Chai, Email: Chaiguangquan@126.com.

References

  • 1.Nashef A, Qabaja R, Salaymeh Y, Botzman M, Munz M, Dommisch H, Krone B, Hoffmann P, Wellmann J, Laudes M, Berger K, Kocher T, Loos B, van der Velde N, Uitterlinden AG, de Groot LCPGM, Franke A, Offenbacher S, Lieb W, Divaris K, Mott R, Gat-Viks I, Wiess E, Schaefer A, Iraqi FA, Haddad YH. Integration of murine and human studies for mapping periodontitis susceptibility. J Dent Res. 2018;97(5):537–546. doi: 10.1177/0022034517744189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15(1):30–44. doi: 10.1038/nri3785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Righolt AJ, Jevdjevic M, Marcenes W, Listl S. Global-, regional-, and country-level economic impacts of dental diseases in 2015. J Dent Res. 2018;97(5):501–507. doi: 10.1177/0022034517750572. [DOI] [PubMed] [Google Scholar]
  • 4.Gross AJ, Paskett KT, Cheever VJ, Lipsky MS. Periodontitis: a global disease and the primary care provider's role. Postgrad Med J. 2017;93(1103):560–565. doi: 10.1136/postgradmedj-2017-134801. [DOI] [PubMed] [Google Scholar]
  • 5.Slots J. Periodontitis: facts, fallacies and the future. Periodontol 2000. 2017;75(1):7–23. doi: 10.1111/prd.12221. [DOI] [PubMed] [Google Scholar]
  • 6.Fouad AF, Khan AA, Silva RM, Kang MK. Genetic and epigenetic characterization of pulpal and Periapical inflammation. Front Physiol. 2020;11:21. doi: 10.3389/fphys.2020.00021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Li S, Liu X, Zhou Y, Acharya A, Savkovic V, Xu C, Wu N, Deng Y, Hu X, Li H, Haak R, Schmidt J, Shang W, Pan H, Shang R, Yu Y, Ziebolz D, Schmalz G. Shared genetic and epigenetic mechanisms between chronic periodontitis and oral squamous cell carcinoma. Oral Oncol. 2018;86:216–224. doi: 10.1016/j.oraloncology.2018.09.029. [DOI] [PubMed] [Google Scholar]
  • 8.Elshabrawy HA, Chen Z, Volin MV, Ravella S, Virupannavar S, Shahrara S. The pathogenic role of angiogenesis in rheumatoid arthritis. Angiogenesis. 2015;18(4):433–448. doi: 10.1007/s10456-015-9477-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Polverini PJ. The pathophysiology of angiogenesis. Crit Rev Oral Biol Med. 1995;6(3):230–247. doi: 10.1177/10454411950060030501. [DOI] [PubMed] [Google Scholar]
  • 10.Melincovici CS, Bosca AB, Susman S, Marginean M, Mihu C, Istrate M, et al. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Romanian J Morphol Embryol. 2018;59(2):455–467. [PubMed] [Google Scholar]
  • 11.Andrikopoulos P, Fraser SP, Patterson L, Ahmad Z, Burcu H, Ottaviani D, Diss JKJ, Box C, Eccles SA, Djamgoz MBA. Angiogenic functions of voltage-gated Na+ channels in human endothelial cells: modulation of vascular endothelial growth factor (VEGF) signaling. J Biol Chem. 2011;286(19):16846–16860. doi: 10.1074/jbc.M110.187559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gunesacar R, Erken E, Ozer HT, Bozkurt B, Dinkci S, Deveci D. Analysis of vascular endothelial growth factor gene 936 C/T polymorphism in patients with familial Mediterranean fever. Int J Immunogenet. 2008;35(1):33–36. doi: 10.1111/j.1744-313X.2007.00730.x. [DOI] [PubMed] [Google Scholar]
  • 13.Fu ZZ, Sun XD, Li P, Zhang Z, Li GZ, Gu T, Shao SS. Relationship between serum VEGF level and radiosensitivity of patients with nonsmall cell lung cancer among asians: a meta-analysis. DNA Cell Biol. 2014;33(7):426–437. doi: 10.1089/dna.2013.2249. [DOI] [PubMed] [Google Scholar]
  • 14.Chen J, Li T, Wu Y, He L, Zhang L, Shi T, Yi Z, Liu M, Pang X. Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis. J Cancer Res Clin Oncol. 2011;137(12):1799–1812. doi: 10.1007/s00432-011-1057-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019;176(6):1248–1264. doi: 10.1016/j.cell.2019.01.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Karatas O, Balci Yuce H, Tulu F, Taskan MM, Gevrek F, Toker H. Evaluation of apoptosis and hypoxia-related factors in gingival tissues of smoker and non-smoker periodontitis patients. J Periodontal Res. 2019. [DOI] [PubMed]
  • 17.Balci Yuce H, Karatas O, Tulu F, Altan A, Gevrek F. Effect of diabetes on collagen metabolism and hypoxia in human gingival tissue: a stereological, histopathological, and immunohistochemical study. Biotech Histochem. 2019;94(1):65–73. doi: 10.1080/10520295.2018.1508745. [DOI] [PubMed] [Google Scholar]
  • 18.Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100. doi: 10.1371/journal.pmed.1000100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882–883. doi: 10.1093/bioinformatics/bts034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. doi: 10.1038/s41467-019-09234-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Zintzaras E, Ioannidis JP. HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics. 2005;21(18):3672–3673. doi: 10.1093/bioinformatics/bti536. [DOI] [PubMed] [Google Scholar]
  • 22.Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634. doi: 10.1136/bmj.315.7109.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101. doi: 10.2307/2533446. [DOI] [PubMed] [Google Scholar]
  • 24.Artese L, Piattelli A, de Gouveia Cardoso LA, Ferrari DS, Onuma T, Piccirilli M, Faveri M, Perrotti V, Simon M, Shibli JA. Immunoexpression of angiogenesis, nitric oxide synthase, and proliferation markers in gingival samples of patients with aggressive and chronic periodontitis. J Periodontol. 2010;81(5):718–726. doi: 10.1902/jop.2010.090524. [DOI] [PubMed] [Google Scholar]
  • 25.Kasprzak A, Surdacka A, Tomczak M, Przybyszewska W, Seraszek-Jaros A, Malkowska-Lanzafame A, Siodla E, Kaczmarek E. Expression of angiogenesis-stimulating factors (VEGF, CD31, CD105) and angiogenetic index in gingivae of patients with chronic periodontitis. Folia Histochem Cytobiol. 2012;50(4):554–564. doi: 10.5603/FHC.2012.0078. [DOI] [PubMed] [Google Scholar]
  • 26.Kubota T, Morozumi T, Shimizu K, Sugita N, Kobayashi T, Yoshie H. Differential gene expression in neutrophils from patients with generalized aggressive periodontitis. J Periodontal Res. 2001;36(6):390–397. doi: 10.1034/j.1600-0765.2001.360607.x. [DOI] [PubMed] [Google Scholar]
  • 27.Loo WT, Wang M, Jin LJ, Cheung MN, Li GR. Association of matrix metalloproteinase (MMP-1, MMP-3 and MMP-9) and cyclooxygenase-2 gene polymorphisms and their proteins with chronic periodontitis. Arch Oral Biol. 2011;56(10):1081–1090. doi: 10.1016/j.archoralbio.2011.03.011. [DOI] [PubMed] [Google Scholar]
  • 28.Lucarini G, Zizzi A, Aspriello SD, Ferrante L, Tosco E, Lo Muzio L, Foglini P, Mattioli-Belmonte M, di Primio R, Piemontese M. Involvement of vascular endothelial growth factor, CD44 and CD133 in periodontal disease and diabetes: an immunohistochemical study. J Clin Periodontol. 2009;36(1):3–10. doi: 10.1111/j.1600-051X.2008.01338.x. [DOI] [PubMed] [Google Scholar]
  • 29.Ramya KS. Expression of VEGF in periodontal tissues of type II diabetes mellitus patients with chronic periodontitis -an Immunohistochemical study. J Clin Diagn Res. 2014;8(8):ZC01–ZC03. doi: 10.7860/JCDR/2014/7772.4664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Taskan MM, Karatas O, Balci Yuce H, Isiker Kara G, Gevrek F, Ucan YF. Hypoxia and collagen crosslinking in the healthy and affected sites of periodontitis patients. Acta Odontol Scand. 2019;77(8):600–607. doi: 10.1080/00016357.2019.1624819. [DOI] [PubMed] [Google Scholar]
  • 31.Tian Y, Li JL, Hao L, Yue Y, Wang M, Loo WT, Cheung MN, Chow LW, Liu Q, Yip AY, Ng EL, Chow CY, Chow CY. Association of cytokines, high sensitive C-reactive protein, VEGF and beta-defensin-1 gene polymorphisms and their protein expressions with chronic periodontitis in the Chinese population. Int J Biol Markers. 2013;28(1):100–107. doi: 10.5301/JBM.5000010. [DOI] [PubMed] [Google Scholar]
  • 32.Unlu F, Guneri PG, Hekimgil M, Yesilbek B, Boyacioglu H. Expression of vascular endothelial growth factor in human periodontal tissues: comparison of healthy and diabetic patients. J Periodontol. 2003;74(2):181–187. doi: 10.1902/jop.2003.74.2.181. [DOI] [PubMed] [Google Scholar]
  • 33.Yuan K, Jin YT, Lin MT. The detection and comparison of angiogenesis-associated factors in pyogenic granuloma by immunohistochemistry. J Periodontol. 2000;71(5):701–709. doi: 10.1902/jop.2000.71.5.701. [DOI] [PubMed] [Google Scholar]
  • 34.Hu Y, Su L, Liang H. Expression and significance of vascular endothelial growth factor and ICAM-1 in gingival tissue of patients with chronic periodontitis. Mod Diagn Treat. 2019;30(03):16–18. [Google Scholar]
  • 35.Li J, Chu Y, Ye J, Wang M, Chen F, Wang X, et al. Angiogenesis in Chronic Periodontitis. Chin J Conserv Dent. 2014;24:1. [Google Scholar]
  • 36.Shimpi N, McRoy S, Zhao H, Wu M, Acharya A. Development of a periodontitis risk assessment model for primary care providers in an interdisciplinary setting. Technol Health Care. 2020;28(2):143–154. doi: 10.3233/THC-191642. [DOI] [PubMed] [Google Scholar]
  • 37.Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;3(1):17038. doi: 10.1038/nrdp.2017.38. [DOI] [PubMed] [Google Scholar]
  • 38.Jin SH, Zhou RH, Guan XY, Zhou JG, Liu JG. Identification of novel key lncRNAs involved in periodontitis by weighted gene co-expression network analysis. J Periodontal Res. 2020;55(1):96–106. doi: 10.1111/jre.12693. [DOI] [PubMed] [Google Scholar]
  • 39.Shungin D, Haworth S, Divaris K, Agler CS, Kamatani Y, Keun Lee M, Grinde K, Hindy G, Alaraudanjoki V, Pesonen P, Teumer A, Holtfreter B, Sakaue S, Hirata J, Yu YH, Ridker PM, Giulianini F, Chasman DI, Magnusson PKE, Sudo T, Okada Y, Völker U, Kocher T, Anttonen V, Laitala ML, Orho-Melander M, Sofer T, Shaffer JR, Vieira A, Marazita ML, Kubo M, Furuichi Y, North KE, Offenbacher S, Ingelsson E, Franks PW, Timpson NJ, Johansson I. Genome-wide analysis of dental caries and periodontitis combining clinical and self-reported data. Nat Commun. 2019;10(1):2773. doi: 10.1038/s41467-019-10630-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Guzeldemir-Akcakanat E, Alkan B, Sunnetci-Akkoyunlu D, Gurel B, Balta VM, Kan B, Akgun E, Yilmaz EB, Baykal AT, Cine N, Olgac V, Gumuslu E, Savli H. Molecular signatures of chronic periodontitis in gingiva: a genomic and proteomic analysis. J Periodontol. 2019;90(6):663–673. doi: 10.1002/JPER.18-0477. [DOI] [PubMed] [Google Scholar]
  • 41.Matsumoto K, Ema M. Roles of VEGF-A signalling in development, regeneration, and tumours. J Biochem. 2014;156(1):1–10. doi: 10.1093/jb/mvu031. [DOI] [PubMed] [Google Scholar]
  • 42.Pradeep CR, Sunila ES, Kuttan G. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies. Integr Cancer Ther. 2005;4(4):315–321. doi: 10.1177/1534735405282557. [DOI] [PubMed] [Google Scholar]
  • 43.Hegde PS, Wallin JJ, Mancao C. Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics. Semin Cancer Biol. 2018;52(Pt 2):117–124. doi: 10.1016/j.semcancer.2017.12.002. [DOI] [PubMed] [Google Scholar]
  • 44.Zafar MI, Mills K, Ye X, Blakely B, Min J, Kong W, Zhang N, Gou L, Regmi A, Hu SQ, Zheng J, Chen LL. Association between the expression of vascular endothelial growth factors and metabolic syndrome or its components: a systematic review and meta-analysis. Diabetol Metab Syndr. 2018;10(1):62. doi: 10.1186/s13098-018-0363-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Jiang L, Sun JH, Quan LN, Tian YY, Jia CM, Liu ZQ, Liu AC. Abnormal vascular endothelial growth factor protein expression may be correlated with poor prognosis in diffuse large B-cell lymphoma: a meta-analysis. J Cancer Res Ther. 2016;12(2):605–611. doi: 10.4103/0973-1482.146086. [DOI] [PubMed] [Google Scholar]
  • 46.Chen M, Cai E, Huang J, Yu P, Li K. Prognostic value of vascular endothelial growth factor expression in patients with esophageal cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2012;21(7):1126–1134. doi: 10.1158/1055-9965.EPI-12-0020. [DOI] [PubMed] [Google Scholar]
  • 47.Qiu M, Xiong W, Liao H, Li F. VEGF -634G>C polymorphism and diabetic retinopathy risk: a meta-analysis. Gene. 2013;518(2):310–315. doi: 10.1016/j.gene.2013.01.018. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Additional file 1:. (346.2KB, tif)
12950_2021_281_MOESM2_ESM.docx (17.8KB, docx)

Additional file 2: Table S1. Study characteristics of the included studies on VEGF positive expression.

12950_2021_281_MOESM3_ESM.docx (15.3KB, docx)

Additional file 3: Table S2. Sensitivity analysis.

Data Availability Statement

The datasets used or/and analyzed during the current study are available from the corresponding author on reasonable request.

Articles from Journal of Inflammation (London, England) are provided here courtesy of BMC

RESOURCES